Immunologic tolerance to solid organ and islet cell grafts has been achieved in various rodent models by using antibodies directed at CD45RB and Tim-1. We have shown that this form of tolerance depends on regulatory B cells (Bregs). To elucidate further the mechanism by which Bregs induce tolerance, we investigated the requirement of natural killer (NK) and NKT cells in this model. To do so, hyperglycemic B6, lMT, Beige, or CD1d À/À mice received BALB/c islet grafts and treatment with the toleranceinducing regimen consisting of anti-CD45RB and anti-TIM1. B6 mice depleted of both NK and NKT cells by anti-NK1.1 antibody and mice deficient in NK activity (Beige) did not develop tolerance after dualantibody treatment. In contrast, transplant tolerance induction was successful in CD1d À/À recipients (deficient in NKT cells), indicating that NK, but not NKT, cells are essential in B cell-dependent tolerance. In addition, reconstitution of Beige host with NK cells restored the ability to induce transplant tolerance with dual-antibody treatment. Transfer of tolerance by B cells from tolerant mice was also dependent on host Nk1.1 + cells. In conclusion, these results show that regulatory function of B cells is dependent on NK cells in this model of transplantation tolerance.
Introduction
Several therapeutic antibodies have enabled transplantation tolerance in murine models. While most of these antibodies evoke well-characterized pathways such as costimulatory blockade or cell adhesion to induce tolerance, the mechanistic underpinning of other tolerance inducing antibodies is less clear. We and others have used an antibody binding CD45RB to induce immune tolerance to heterotopically transplanted allogeneic hearts and pancreatic islets (1, 2) . More recently, we found that CD45RB acts synergistically with Tim-1 antibody that has been shown independently to induce tolerance to islet grafts (3) . While the detailed mechanisms have yet to be identified, we and others have found that the tolerance induced by these antibodies is dependent on both regulatory B cells (Bregs) and regulatory T cells (Tregs). More specifically, while the adoptive transfer of Bregs alone is sufficient to induce antigen-specific transplant tolerance, it requires the presence of Tregs in the recipient (3, 4) .
The biology of Bregs has been under intense investigation in recent years, resulting in the emergence of a diversity of functional subsets and regulatory mechanisms (5, 6) . A frequently described hallmark of Bregs, and the greatest common denominator of all subtypes, is the production of the immunomodulatory cytokine interleukin (IL)-10 (5). However, it has become apparent that other mechanisms are at play, and IL-10 is not always required for B cells to exert immunoregulatory functions (7) . Nevertheless, the phenotypic diversity of Bregs appears to be greater than that of Tregs, and while Tregs are considered a distinct cell lineage, immune regulation may represent a functional state that many types of B cells can acquire in the appropriate context (5) . A unique and unifying transcription factor such as FoxP3 for Tregs has not been identified for Bregs (8) , further supporting the hypothesis of Breg plasticity and functional diversity. Thus far, the search for a Breg marker has been limited to its correlation with IL-10 expression in B cells, leading to the identification of a variety of putative Breg markers, including Tim-1(9), CD9 (8) 
Materials and Methods

Mice
Female BALB/c and male C57BL/6 (B6), B6lMT
), and B6.C3Rl-Lyst bg /J (Beige, NK cell deficient) mice were purchased from Jackson Laboratories (Bar Harbor, ME). All mice were housed under specific pathogen-free barrier conditions. All procedures were performed under the principles of laboratory animal care and approved by the IACUC committee at the Massachusetts General Hospital.
Hyperglycemia was induced in C57BL/6 mice or B6lMT À/À mice through intraperitoneal injection of 200 mg/kg streptozotocin (STZ; Sigma-Aldrich, St. Louis, MO) and was defined as blood glucose levels >300 mg/dL for 3 consecutive days. Islets from BALB/c donors were isolated through the previously described technique of enzymatic digestion (Liberase DL; Roche, Indianapolis, IN) and density gradient purification (Euro-collins/Polysucrose; Cellgro, Mediatech, Manassas, VA). From 300 to 400 fresh islets were transplanted under the kidney capsule of diabetic mice. Euglycemia was defined as a nonfasting blood glucose level <200 mg/dL. Islet graft rejection was diagnosed when animals became hyperglycemic again, with blood glucose >200 mg/dL for at least 3 consecutive days. Allograft function was confirmed by nephrectomy of the islet graft bearing kidney. All recipients with long-term functional grafts became hyperglycemic within 48 h of nephrectomy (data not shown).
Antibody treatment
For induction of tolerance, 100 lg of anti-CD45RB mAbs was administered intraperitoneally. on days 0, 1, 3, 5, and 7 after transplantation, as well as antagonistic anti-TIM-1 mAbs (RMT1-10) on day -1 (500 lg) and on days 0 and 5 (300 lg) posttransplantation. 
Flow cytometry
Lymphocytes were prepared from the spleen of mice that were transplanted and treated with combined antibody therapy. The following antibodies were used for staining: CD4 À (PECy7), B220 (Pacific Blue), Foxp3
(APC), Tim-1/CD365 (clone RMT1-4; biotin), anti-CD49b (clone DX5), Foxp3 staining buffer kit (all from eBioscience, San Diego, CA), streptavidin-A750 (Invitrogen, Grand Island, NY), and NK1.1 (PK136; BioXcell, Lebanon, NH). Cells were analyzed on an LSRII cytometer (Becton Dickinson, San Diego, CA), and the results were analyzed with FlowJo software (Treestar, Ashland, OR).
Statistical analysis
For survival studies, Kaplan-Meier survival curves were generated and statistical analysis performed by use of the log-rank (Mantel-Cox) test. The t-test was used to test significance of quantitative differences in immune cell populations. All data were analyzed by using the Prism 5 Software (Graph Pad, San Diego, CA). A value of p < 0.05 was considered significant.
Results
Dual-antibody treatment causes quantitative shift in NK and NKT cells
We observed that in dual-antibody (anti-CD45RB, anti-TIM1)-mediated islet transplant tolerance, the proportions of NK1.1 + cells are skewed in favor of NKT cells ( Figure 1 ). While we do not know if this shift is causally associated with tolerance, the expression of CD1d on Bregs (10) lead us to hypothesize that interactions between Bregs and CD1d restricted iNKT cells are involved in the induction of tolerance. 
NK1.1 + cells are required for induction but not maintenance of islet transplant tolerance
The high rate of long-term immunologic tolerance to allogeneic islet grafts achieved by dual-antibody treatment (3) is completely abrogated when the recipient B6 mice are depleted of NK1.1 + cells before transplantation (Figure 2A) . The anti-NK1.1 antibody potently depletes NKT and NK cells in B6 mice for at least 4 weeks after the injection of a single dose. Homeostatic NK cell repopulation after depletion has been shown to be incomplete (11) (12) (13) (14) and does not appear to interfere with B cell-dependent transplant tolerance. Therefore, we assessed whether depletion of NK1.1 + cells abrogates tolerance after tolerance has been established with dual-antibody treatment. Interestingly, depletion at 30 days post-islet transplantation did not affect transplant tolerance persistence (Figure 2A ). Depletion of NK cells was confirmed by flow cytometry of recipient mice, 16 days posttransplantation ( Figures 3A and B) . -/-mice exhibit low levels of NKT cell-derived cytokines such as IL-4, IL-2, interferon (INF)c, tumor necrosis factor (TNF)a, and granulocyte-macrophage colony-stimulating factor due to the complete absence of NKT cell function (15) . Unexpectedly, dual-antibody treatment rendered >60% of CD1d-deficient recipients tolerant to an allogeneic BALB/c islet graft ( Figure 4A ). The reduced proportion of tolerant animals compared with wild-type B6 recipients may be attributable to the overall abnormal immune response in these animals, including a stronger type 1 T helper cell response. The finding that a majority of mice acquired tolerance, albeit fewer than in wild-type mice, suggests that NKT cells are dispensable for tolerance induction but may have a supporting role.
Further, to specifically probe the role of CD1d expression on Bregs, we transferred splenocytes from CD1d À/À mice to B cell-deficient mice and transplanted these reconstituted mice with BALB/c islets. Dualantibody treatment was able to induce tolerance in these mice, despite the lack of CD1d expression on B cells ( Figure 4B ). Therefore, CD1d-restricted lipid antigen presentation by Bregs to iNKT cells is not a requisite for the establishment of transplantation tolerance in this model ( Figure 4B ).
NK cell deficiency prevents transplantation tolerance In the absence of NKT cells in the CD1d
À/À recipient model, we tested whether depletion of other NK1. antibody (clone Pk136), in the absence of NKT cells, reduced the number of long-term tolerant mice (Figure 5A ).
To further assess the requirement of NK cells in this tolerance model, Beige mice (B6 background) were transplanted with BALB/c islets and treated with dual antibodies. Beige mice have a complex immune deficiency secondary to a lysosomal defect, preventing the formation of functional endosomes. However, a dominant defect is the lack of functional NK cells in these mice, making them a suitable model to study NK cell function. In Beige mice, dual-antibody treatment could not significantly prolong islet graft survival for more than a few days compared with wild-type B6 mice (Figure 5B) . Reconstitution with NK cells from wild-type B6 mice restores tolerance in these mice, further suggesting that it is the defect in NK cell function, rather than other functional defects, that prevents the induction of transplant tolerance ( Figure 5B ).
Discussion
In our effort to elucidate the mechanism underlying Bregdependent transplantation tolerance, induced by treatment with the antibodies anti-CD45RB and anti-TIM1, we found that NK cells play an integral part in the induction of tolerance. We and others have previously shown that antibody-induced tolerance models are dependent on Bregs (1,3,9) . The preceding decade of tolerance research has revealed much about the biology of Tregs. However, as our capability of interrogating complex biological networks expands (16) , it is becoming increasingly clear that many immune cells possess regulatory functions (17) . Bregs have recently emerged as a potent immunoregulatory element that is being studied intensively (5,6). NK cells have long been viewed as the only effector cells of the innate immune system, capable of distinguishing between self and nonself and attacking infected cells as well as transformed tumor cells. New subsets of innate effector cells have since been discovered and classified as innate lymphoid cells (18) . More recently, it has become apparent that NK cells harbor many of the characteristics of the adaptive immune system, including clonal expansion and memory formation (19, 20) , antigen-specific receptors (21) , and an MHC-dependent education process (22) . Further, NK cells have previously been implicated in transplantation tolerance (23) (24) (25) and immune regulation. Even though the immune regulatory role of NK cells was recognized >10 years ago (13) , the underlying mechanisms have not been well delineated. Thus far, our study has focused on interactions between Bregs and Tregs based on the observation that the dualantibody treatment-induced tolerance is dependent on the presence of both (1,3) . The presented findings add another layer of complexity to the tolerance mechanism as it is dependent on a third cell type, NK1.1 + NK cells. In B cell-deficient, but NK cell-replete, lMT mice, tolerance cannot be induced with dual-antibody treatment(3). In addition, NK cell depletion in B cell-deficient lMT mice prevents tolerance induction by transferred tolerogenic B cells, further emphasizing the interdependence of the two cell types (3). While Bregs are required for maintenance of tolerance beyond day 9 posttransplantation (3), we found that the depletion of NK cells after 30 days does not thwart tolerance in this transplant model. Therefore, early posttransplantation interactions of NK cells with Bregs are required for tolerance induction, but thereafter, Bregs maintain tolerance without the need for NK cells. This may be interpreted in a way that Bregs depend on NK cell help for their development, but Bregs, and not NK cells, actively suppress the allogeneic immune response. However, in other models of transplant tolerance and immunity, NK cells have been found to actively control the immune response by suppressing the activity of alloreactive CD8 + T cells (26), monocytes and macrophages (12), CD4 + T cells and follicular helper T cells, and B cells (11) . We did not observe a quantitative change in Bregs or Tregs in NK1.1-depleted mice ( Figures 3C and  D) , but their donor-specific regulatory function may depend on NK-cells, or is directed towards them.
In tumor and infection models, Bregs can suppress the immune responses of NK cells and CD8 + T cells. Activated by CD40L on tumor cells, Bregs secrete IL-10, which suppresses IFNc production by NK cells (27) . In an IL-10-independent mechanism, intratumoral B cells recruit and expand Tregs, thereby preventing infiltration mice, rescuing islet transplantation tolerance induction with dual-antibody treatment (blue) approaching the 100% tolerance rate in wild-type B6 mice (red). In contrast, dual-antibody treatment fails to efficiently induce tolerance to allogeneic islet grafts in nonreconstituted, B cell-deficient, µMT mice (black) (p = 0.033,*). of CD49 + NK cells and CD8 + T cells (28) . Similarly, in an infection model, mice with MyD88 and TLR2 deficient Bcells exhibit a deficient IL-10 response in B cells while the activity of NK cells, neutrophils, and T cells is increased and a Salmonella typhi infection is cleared more effectively (29) . In contrast to this Breg-mediated restraint of NK cell activity, the results presented here and by other investigators (12, 24, 26, 30) may suggest either that Bregs and NK cells act synergistically in regulating the allogeneic immune response or that NK cells provide help to Bregs.
A classic view of NK cell functions involves the monitoring of the cell surface for markers of self-identity such as MHC class I and others as well as markers for cellular stress and/or malignant transformation. In addition, a more complex regulation of their function has emerged in recent years; NK cells exert a constant tension between engagement of a plethora of activating and inhibiting receptors (31) . NK cells were found to exhibit remarkable phenotypical and functional diversity and dynamic plasticity. Apart from conventional NK cells in the spleen, blood, and other organs, several characteristic tissue resident NK cells have been identified (32) . The environment is able to influence the development and phenotype of NK cells (33) , possibly including the influence of Bregs. Observations in virus infection suggest that NK cells may regulate the amount of follicular T helper cells to regulate the activation of B cells in the spleen (11, 34) . Therefore, NK cells may not directly act to exert immunoregulatory function but may influence B cell development, phenotype, and activity.
Our finding of NK cell involvement in dual antibodyinduced transplantation tolerance echoes a number of previous studies using a variety of antibodies to induce transplantation tolerance (12, 24, 25, 30) . In these studies, it has been demonstrated that MHC class I expression and, therefore, missing-self mechanism are not required to induce tolerance with anti-CD40L or anti-LFA1 antibodies, while NK cell perforin was essential (24) . The target of NK cell toxicity had not been identified, but it did not appear to be donor APCs (24) . On the other hand, using the immunologic more rigorous skin transplant model, two independent studies have suggested that NK cells mediate tolerance by targeting donor-derived APCs (25, 30) . Other studies into the immunoregulatory function of NK cells have demonstrated the involvement of cytokines secreted by NK cells (i.e. IFNc, TNFa, and granulocyte-macrophage colony-stimulating factor). However, similar to Tregs and Bregs, Il-10 has been shown to be secreted by NK cells with regulatory function (35) . In turn, it has also been shown that transforming growth factor-b secreted by Tregs can downregulate NK cell cytotoxicity (36) .
Finally, an additional NK1.1 + cell type has recently been identified, which exhibits hallmarks of both B cells and NK cells. These cells develop from B cell precursors and lack the cytotoxic granules and receptor diversity of NK cells. In mycobacterial infection, they activate NK cells and therefore are the earliest effector cells that activate the immune system toward invading pathogens. These so-called NK-like B cells may also be depleted in the islet recipient mice and may be required for the induction of allogeneic transplant tolerance (37) . iNKT cells also exhibit considerable diversity reminiscent of types 1, 2, and 17 helper T cells, including a Nk1.1 -population in B6 mice (38) . We did not find convincing evidence that iNKT cells play a key role in this tolerance model.
While this and other studies establish a significant role of NK cells in transplantation tolerance, the findings are limited because the underlying mechanisms remain unclear. We cannot yet explain how NK cells, Bregs, and Tregs converge on regulating the alloimmune response. Further, some of the animal models used in this work have complex immune alterations with potentially unaccounted effects on outcomes. Ultimately, the translational potential of the investigated tolerance mechanisms will need to be tested in pre-clinical or clinical trials.
In summary, we have identified an essential role for NK cells in B cell-dependent transplantation tolerance. The results presented herein suggest that the two cell types are interdependent in the induction but not maintenance of tolerance. We are currently working to elucidate the underlying mechanisms in greater detail. The recent appreciation of a remarkable functional diversity, plasticity, and redundancy of both cell types in regulation of the immune response (5, 17, 32) points towards a number of potentially interdependent mechanisms.
